Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
residual concentration | drug still measurable after a defined elapsed interval | A residual concentration was measured the day after the last recorded dose. | Objective | Drug levels - collection and dose timing |
steady-state concentration | concentration at a specified point once repeated-dose exposure has stabilized | The reported steady-state concentration refers to the predose point in the dosing interval. | Assessment | Drug levels - exposure and pharmacokinetics |
target concentration | patient- or protocol-specific concentration being sought | The transplant team's target concentration is recorded with the specimen type. | Assessment | Drug levels - exposure and pharmacokinetics |
total concentration | bound and unbound drug measured together | The total concentration was measured on the same draw as free drug. | Objective | Drug levels - analyte, specimen and reporting |
urine sodium concentration | sodium per unit volume in the urine specimen | The urine sodium concentration was interpreted with sampling time and diuretic exposure. | Objective | Glucose monitoring, endocrine testing and urine studies |
aldosterone-renin ratio | aldosterone concentration divided by a stated renin measure | The aldosterone-renin ratio was recorded with units, posture and relevant medicines. | Objective | Glucose monitoring, endocrine testing and urine studies |
amikacin | aminoglycoside with drug- and regimen-specific concentration targets | The amikacin concentration is documented with the dialysis session time. | Objective | Drug levels - named analytes and exposure reports |
assay method | technique used to obtain a reported concentration | The assay method is specified on the transplant laboratory report. | Objective | Drug levels - analyte, specimen and reporting |
attention | ability to focus and sustain concentration | Sustained attention wanes after several questions. | Objective | Cognition, speech and observed behavior |
AUC/MIC | drug exposure divided by the organism's minimum inhibitory concentration | The consult reports AUC/MIC and states the MIC and method used. | Assessment | Drug levels - exposure and pharmacokinetics |
| area under the concentration-time curve across 24 hours | The calculated AUC24 is recorded in mg*h/L. | Assessment | Drug levels - exposure and pharmacokinetics | |
back-extrapolated peak | peak estimated retrospectively from a later concentration and a model | Record the back-extrapolated peak separately from the measured sample. | Plan | Drug levels - verification and documentation |
baseline level | concentration measured before a defined change | The baseline level predates the formulation switch. | Objective | Drug levels - collection and dose timing |
blood-to-plasma ratio | whole-blood concentration divided by plasma concentration | The reported blood-to-plasma ratio was specific to the assay and sampling conditions. | Assessment | Drug concentrations, exposure and assay interpretation |
calibration curve | relationship between instrument response and known concentration | The laboratory report references the validated calibration curve. | Objective | Drug levels - analyte, specimen and reporting |
clozapine | antipsychotic whose concentration may be reported with its metabolite | The laboratory reports clozapine and norclozapine as separate analytes. | Objective | Drug levels - named analytes and exposure reports |
| maximum concentration in the specified concentration-time profile | The model's Cmax is listed separately from the single timed sample. | Assessment | Drug levels - exposure and pharmacokinetics | |
| minimum concentration in the specified concentration-time profile | The modeled Cmin corresponds to the end of the stated interval. | Assessment | Drug levels - exposure and pharmacokinetics | |
comparison target | specific benchmark used to judge a concentration | Match the comparison target to the indication and specimen type. | Plan | Drug levels - verification and documentation |
context-sensitive half-time | time for concentration to fall by half after stopping an infusion of a specified duration | The context-sensitive half-time was interpreted in the context of the prolonged infusion. | Assessment | Drug concentrations, exposure and assay interpretation |
digoxin | cardiac glycoside for which dose-to-draw time affects concentration interpretation | The digoxin result was collected two hours after the reported dose. | Objective | Drug levels - named analytes and exposure reports |
dilute | reduce concentration by adding a compatible diluent | Verify the product-specific instructions before staff dilute the dose. | Plan | Medication planning, access and administration |
Diminished ability to concentrate | Poor concentration | The patient reports diminished ability to concentrate during sustained reading. | Subjective | Neurologic, cognitive and sleep history |
distribution half-life | time for the concentration contribution of the distribution phase to decrease by half | The early decline reflects the distribution half-life in the fitted two-compartment model. | Assessment | Drug concentrations, exposure and assay interpretation |
dose-normalized AUC | area under the concentration-time curve divided by the administered dose | The team compared dose-normalized AUC using the same AUC interval in both periods. | Assessment | Drug concentrations, exposure and assay interpretation |